Meropenem-Vaborbactam
ML-VAB-201-3248-2
Phase 2 small_molecule active
Quick answer
Meropenem-Vaborbactam for Complicated Urinary Tract Infection (cUTI), Acute Pyelonephritis (AP) is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Complicated Urinary Tract Infection (cUTI), Acute Pyelonephritis (AP)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active